Just incase you missed something along the way. Providing...

Just incase you missed something along the way.
Providing investors with further near-term revenue visibility was news that MXC's medical cannabis growing operations would commence in the Czech Republic with Panax this week, with an outdoor crop being planted by late April/May 2017.

On the distribution front, MGC Derma is in advanced discussions with cosmetic distributors, retailers and e-tailers in the UK and Europe with former Revlon Director, Malcolm Kemp looking to commence sales into these markets at some stage in 2017.

The company received its first major sales order and commencement of revenues from its Czech Republic distribution deal for its MGC Derma cannabidiol-based cosmetic products with Czech Medical Herbs s.r.o. (CMH).

CMH is the exclusive distributor for MGC Derma products in the Czech Republic and is a specialist company in the field of cannabis for medical uses, demonstrating that the company is already well equipped to sell into the medical cannabis market.

MXC's agreement with CMH is for the distribution of MGC Derma cosmetics products to over 80 retail outlets in the Czech Republic. This represented the commencement of the company's second revenue stream, complementing its first exclusive distribution deal in California.

The sales order was expected to generate revenues of $65,000, part of the entire distribution agreement valued at circa $500,000 in annual gross sales.

Having experience with supply chain management, including adherence to proper distribution protocols should provide MXC with an added advantage in terms of being accepted into new markets such as Australia.


Read more at https://finance.nine.com.au/2017/02...r-medical-cannabis-market#w02Xk4FGkDyQUAv9.99